We report the changes of phenotype and antitumor cytolytic activity of glioma-infiltrating lymphocytes ( GIL) before and after recombinant interleukin-2 ( rIL-2) and thymic factor D ( TFD). 经重组白细胞介素2(rIL-2)和胸腺因子D(TFD)培养前后的人脑胶质瘤浸润淋巴细胞(GIL)的表型及抗自体瘤细胞活性变化。